Our Private Equity Group is considered the go-to practice for complex, bespoke and firm-defining transactions. With clients ranging from the world’s leading institutional asset managers to prominent middle-market private equity and growth equity firms, we offer comprehensive advice to general partners, limited partners, co-investors and other equity stakeholders, as well as portfolio companies, lenders and financial sponsor groups. The depth and continuity of our relationships across the industry gives us a nuanced understanding of each client’s objectives and allows us to provide seamless, efficient counsel across the investment lifecycle.
Kohlberg to Acquire PCI Pharma
- Client News
- August 24, 2020
Paul, Weiss is advising Kohlberg & Company, LLC in its acquisition of a majority stake in PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, from Partners Group, a global private markets investment manager.
Under the terms of the transaction, Mubadala Investment Company, an Abu Dhabi-based sovereign investor, will also become a significant investor in PCI. Kohlberg and Mubadala plan to partner with PCI's management team, to leverage the global growth trends in biologics and specialized drug therapies to grow specialized manufacturing and expand further into Asia and greater Europe. Financial terms of the transaction were not disclosed.
The Paul, Weiss team includes corporate partners Angelo Bonvino, Sarah Stasny and Thomas de la Bastide and counsel Julie Martinelli, David Harris and Suhan Shim; tax partners Lindsay Parks and Brad Okun; intellectual property partner Charles Googe; real estate partner Peter Fisch; litigation counsel Peter Jaffe; antitrust counsel Marta Kelly; international trade counsel Richard Elliott; environmental counsel William O'Brien; and employee benefits counsel Reuven Falik.